Nova Leap Health Corp
Nova Leap Health Corp operates in the healthcare sector, providing pharmaceutical services and equipment, and generates revenue primarily through its healthcare facilities and services.
Business. Nova Leap Health Corp (NLH.V) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Nova Leap Health Corp is headquartered in Canada and is listed on the TSX Venture Exchange. Specific details regarding operating segments and geographic breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Nova Leap Health Corp (NLH.V) is a healthcare services and equipment company primarily engaged in pharmaceutical activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Nova Leap Health Corp is headquartered in Canada and is listed on the TSX Venture Exchange. Specific details regarding operating segments and geographic breakdowns are not available.
Nova Leap Health Corp maintains a relatively strong liquidity position, with a current ratio of 1.78, indicating the company can cover its short-term liabilities with its short-term assets. The company's cash and equivalents amount to $1,116,760, while its long-term debt is $1,248,940, resulting in a net cash position that is negative after subtracting total debt. The debt-to-equity ratio of 0.07 suggests a conservative capital structure with minimal leverage.
In terms of profitability, the company's return on equity (ROE) is 2.59%, and its return on assets (ROA) is 2.27%, both of which are below the industry median for healthcare facilities and services. The operating margin is 3.36%, and the net profit margin is 7.35%, indicating that the company is generating a modest profit relative to its revenue.
The company's revenue is concentrated in a single segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to regional economic or regulatory risks.
The company's growth trajectory is not clearly defined in the available data, as there are no specific revenue growth projections or historical growth rates provided. The capital expenditure for the period is reported as $0, suggesting that the company is not currently investing in new physical assets.
The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could affect its ability to fund operations without external financing. The dilution risk is low, and there are no significant adjustments applied to the valuation metrics.
Recent events, such as analyst estimates, show that the last actual EPS was -$0.01, and the last actual revenue was $35,325,000. These figures suggest that the company is currently reporting a small loss per share, which may impact investor sentiment and stock performance.
- Nova Leap Health Corp has a conservative capital structure with a low debt-to-equity ratio of 0.07.
- The company's ROE and ROA are below the industry median, indicating lower profitability relative to peers.
- The company's liquidity is moderate, with a current ratio of 1.78, but its net cash position is negative after subtracting total debt.
- The company's revenue is concentrated in a single segment, with no geographic diversification disclosed.
- The company is not currently investing in new physical assets, as indicated by a capital expenditure of $0.
- The company's recent financial performance shows a small loss per share, which may affect investor confidence.
Bull / Bear case
Generated · model-assistedRevenue grew 32.5% year-over-year to $31.5 million in fiscal 2024, demonstrating strong top-line expansion momentum.
Operating income improved to $981,700 in fiscal 2024, indicating successful operational efficiency gains despite revenue growth.
The debt-to-equity ratio of 0.07 is well below the cohort median of 0.32, suggesting a conservative capital structure.
Gross profit increased to $12.5 million in fiscal 2024, reflecting improved cost management or pricing power.
Long-term debt increased to $2.9 million in fiscal 2024, rising from $2.5 million in the previous year.
In focus — financials by report
Revenue $8.3M, +29,0% YoY; Operating income +308,7% YoY.
- ▍Revenue $8.3M, +29,0% YoY
- ▍Operating income +308,7% YoY
- ▍Net income +305,0% YoY
- ▍Free cash flow +1 169,0% YoY
- ▍Net margin 5.2%
Revenue $8.0M, +26,5% YoY; Operating income +67,1% YoY.
- ▍Revenue $8.0M, +26,5% YoY
- ▍Operating income +67,1% YoY
- ▍Net income −313,2% YoY
- ▍Free cash flow −175,2% YoY
- ▍Net margin -6.0%
Revenue $7.1M, +10,3% YoY; Operating income −87,9% YoY.
- ▍Revenue $7.1M, +10,3% YoY
- ▍Operating income −87,9% YoY
- ▍Net income −116,5% YoY
- ▍Free cash flow −81,0% YoY
- ▍Net margin -1.1%
Revenue $6.6M; Operating income $134.9k.
- ▍Revenue $6.6M
- ▍Operating income $134.9k
- ▍Net margin 13.5%
Revenue $6.4M; Operating income $91.9k.
- ▍Revenue $6.4M
- ▍Operating income $91.9k
- ▍Net margin -3.2%
Revenue $6.3M; Operating income $193.3k.
- ▍Revenue $6.3M
- ▍Operating income $193.3k
- ▍Net margin 3.6%
Revenue $6.4M; Operating income $215.9k.
- ▍Revenue $6.4M
- ▍Operating income $215.9k
- ▍Net margin 7.4%
Revenue $31.5M, +22,1% YoY; Operating income +54,4% YoY.
- ▍Revenue $31.5M, +22,1% YoY
- ▍Operating income +54,4% YoY
- ▍Net income −113,8% YoY
- ▍Free cash flow −66,8% YoY
- ▍Net margin -0.6%
Revenue $25.8M, −1,6% YoY; Operating income +180,0% YoY.
- ▍Revenue $25.8M, −1,6% YoY
- ▍Operating income +180,0% YoY
- ▍Net income +230,7% YoY
- ▍Free cash flow +1 080,5% YoY
- ▍Net margin 5.4%
Revenue $26.2M, −7,2% YoY; Operating income +56,6% YoY.
- ▍Revenue $26.2M, −7,2% YoY
- ▍Operating income +56,6% YoY
- ▍Net income −26,2% YoY
- ▍Free cash flow −144,0% YoY
- ▍Net margin -4.0%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Nova Leap Health Corp Market data — financials · 2026-05-28
- Nova Leap Health Corp Market data — analyst estimates · 2026-05-28
Ownership & reference
Leadership
- Chris Donald DobbinPresident, Chief Executive Officer, Director